Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionIFM Investors Pty Ltd
Latest Disclosed Ownership21,032 shares
Latest Disclosed Value $ 16,250,164
IFM Investors Pty Ltd reports 1.42% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On April 24, 2026 - IFM Investors Pty Ltd filed a 13F-HR form disclosing ownership of 21,032 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $16,250,164 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 20,738 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 1.42% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 21,032 294 1.42 16,250 101,462.50 0.1345
2026-02-12 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 20,738 75 0.36 16 -99.86 0.1335
2025-10-15 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 20,663 -634 -2.98 11,652 4.21 0.1024
2025-07-11 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 21,297 49 0.23 11,181 -17.04 0.1064
2025-05-21 2025-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 21,248 -102 -0.48 13,476 -11.39 0.1460
2025-04-29 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 23,285 1,935 24,478 0.2365
2025-04-29 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 21,350 -1,935 -8.31 15,208 -37.87 0.1546
2024-10-23 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 23,285 27 0.12 24,478 0.14 0.2349
2024-08-15 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 23,258 690 3.06 24,445 12.54 0.2479
2024-04-22 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 22,568 -134 -0.59 21,721 114,221.05 0.2369
2024-01-12 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 22,702 -58 -0.25 20 -99.90 0.2428
2023-10-26 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 22,760 1,859 8.89 18,731 24.72 0.2463
2023-07-27 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 20,901 1,045 5.26 15,018 -7.95 0.1967
2023-05-11 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 19,856 466 2.40 16,315 16.63 0.2475
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICAL COM 75886F107 19,390 501 2.65 13,990 7.51 0.2349
2022-10-12 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 18,889 376 2.03 13,012 18.90 0.2365
2022-07-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 18,513 1,104 6.34 10,944 -9.99 0.1920
2022-05-06 2022-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 17,409 3,659 26.61 12,159 40.03 0.1887
2022-04-13 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 17,409 3,659 12,159 0.1902
2022-01-18 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 13,750 -66 -0.48 8,683 3.85 0.1592
2021-10-13 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 13,816 -35 -0.25 8,361 8.08 0.1729
2021-07-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 13,851 2,308 19.99 7,736 41.66 0.1581
2021-05-05 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 11,543 1,523 15.20 5,461 12.81 0.1461
2021-01-13 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 10,020 1,739 21.00 4,841 4.42 0.1538
2020-10-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,281 1,132 15.83 4,636 3.99 0.1944
2020-07-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,149 -1,106 -13.40 4,458 14.16 0.2293
2020-04-09 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 8,255 249 3.11 3,905 29.91 0.1748
2020-01-13 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 8,006 -343 -4.11 3,006 29.79 0.1060
2019-11-01 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,349 2,415 40.70 2,316 24.72 0.0856
2019-07-16 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,934 588 11.00 1,857 -15.40 0.1055
2019-04-18 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,346 765 16.70 2,195 28.29 0.1408
2019-01-23 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,581 426 10.25 1,711 1.91 0.1384
2018-10-22 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,155 588 16.48 1,679 36.39 0.1274
2018-07-09 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,567 1,115 45.47 1,231 45.85 0.1163
2018-05-10 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,452 262 11.96 844 2.55 0.1214
2018-01-29 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,190 0 0.00 823 -15.93 0.1299
2017-11-15 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,190 45 2.10 979 -7.03 0.1652
2017-11-21 2017-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 2,145 517 31.76 1,053 66.88 0.1895
2017-11-21 2017-03-31 13F/A-3 REGENERON PHARMACEUTICALS COM 75886F107 1,628 611 60.08 631 69.17 0.1595
2017-02-16 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,017 1,017 373 0.1757
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.